1st Quarter - Report

CHAMBER HILL STRATEGIES for AMAG PHARMACEUTICALS (FORMERLY KNOWN AS LUMARA PHARMACEUTICAL)

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Implementation issues related to P.L. 113-54, the Drug Quality and Security Act.

LobbyistCovered position, as disclosed
JENNIFER BELL Legislative Assistant, Rep. John Thune (R-SD)
JENNIFER HIGGINS —
MICHAELA SIMS Legislative Director and Counsel, Sen. Bob Kerrey (D-NE)
MARY KATHLEEN ZIRKELBACH New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.